Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2.

Conclusion. Quinupristin represents a potential anti-SARS-CoV-2 therapeutic. At present, we have no evidence that this drug is effective against SARS-CoV-2 but expect that the biomedical community will expeditiously follow up on our in silico findings. PMID: 32469301 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32469301?dopt=Abstract

Source: Journal of Medical Microbiology - May 28, 2020 Category: Microbiology Authors: Pokhrel R, Chapagain P, Siltberg-Liberles J Tags: J Med Microbiol Source Type: research